261 related articles for article (PubMed ID: 33144389)
1. Inhibiting Sialidase-Induced TGF-
Karhadkar TR; Meek TD; Gomer RH
J Pharmacol Exp Ther; 2021 Jan; 376(1):106-117. PubMed ID: 33144389
[TBL] [Abstract][Full Text] [Related]
2. Attenuated pulmonary fibrosis in sialidase-3 knockout (
Karhadkar TR; Chen W; Gomer RH
Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L165-L179. PubMed ID: 31617733
[TBL] [Abstract][Full Text] [Related]
3. The sialidase NEU3 promotes pulmonary fibrosis in mice.
Pilling D; Sahlberg K; Karhadkar TR; Chen W; Gomer RH
Respir Res; 2022 Aug; 23(1):215. PubMed ID: 35999554
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis.
Karhadkar TR; Chen W; Pilling D; Gomer RH
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613682
[TBL] [Abstract][Full Text] [Related]
5. The mRNA-binding protein DDX3 mediates TGF-β1 upregulation of translation and promotes pulmonary fibrosis.
Chen W; Pilling D; Gomer RH
JCI Insight; 2023 Apr; 8(7):. PubMed ID: 36821384
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 increases sialidase 3 expression in human lung epithelial cells by decreasing its degradation and upregulating its translation.
Chen W; Lamb TM; Gomer RH
Exp Lung Res; 2020; 46(3-4):75-80. PubMed ID: 32102576
[No Abstract] [Full Text] [Related]
7. Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model.
Karhadkar TR; Pilling D; Cox N; Gomer RH
Sci Rep; 2017 Nov; 7(1):15069. PubMed ID: 29118338
[TBL] [Abstract][Full Text] [Related]
8. Changes in lung sialidases in male and female mice after bleomycin aspiration.
Pilling D; Sahlberg K; Chen W; Gomer RH
Exp Lung Res; 2022; 48(9-10):291-304. PubMed ID: 36382835
[No Abstract] [Full Text] [Related]
9. Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.
Luzina IG; Lillehoj EP; Lockatell V; Hyun SW; Lugkey KN; Imamura A; Ishida H; Cairo CW; Atamas SP; Goldblum SE
J Pharmacol Exp Ther; 2021 Jan; 376(1):136-146. PubMed ID: 33139318
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
[TBL] [Abstract][Full Text] [Related]
12. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
[TBL] [Abstract][Full Text] [Related]
13. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
14. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.
Kim JH; Kim HY; Kim S; Chung JH; Park WS; Chung DH
Am J Pathol; 2005 Nov; 167(5):1231-41. PubMed ID: 16251408
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
17. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains.
Kolb M; Bonniaud P; Galt T; Sime PJ; Kelly MM; Margetts PJ; Gauldie J
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):141-50. PubMed ID: 12151305
[TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
19. CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis.
Guan S; Zhou J
Mol Biosyst; 2017 Sep; 13(10):2116-2124. PubMed ID: 28820530
[TBL] [Abstract][Full Text] [Related]
20. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
